Shalby Ltd vs Vaidya Sane Ayurved Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Shalby Ltd is ₹ 113.65 as of 23 Oct 15:30 . The P/E Ratio of Shalby Ltd changed from 25.7 on March 2021 to 36.5 on March 2026 . This represents a CAGR of 6.02% over 6 yearsThe P/E Ratio of Vaidya Sane Ayurved Laboratories Ltd changed from 51.1 on March 2023 to 19.5 on March 2026 . This represents a CAGR of -21.40% over 4 years The Market Cap of Shalby Ltd changed from ₹ 1089 crore on March 2021 to ₹ 1370 crore on March 2026 . This represents a CAGR of 3.90% over 6 yearsThe Market Cap of Vaidya Sane Ayurved Laboratories Ltd changed from ₹ 247.07 crore on March 2023 to ₹ 175.15 crore on March 2026 . This represents a CAGR of -8.24% over 4 years The revenue of Shalby Ltd for the Jun '26 is ₹ 338.64 crore as compare to the Mar '26 revenue of ₹ 295.52 crore. This represent the growth of 14.59% The revenue of Vaidya Sane Ayurved Laboratories Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Shalby Ltd for the Jun '26 is ₹ 49 crore as compare to the Mar '26 ebitda of ₹ 37.43 crore. This represent the growth of 30.91% The ebitda of Vaidya Sane Ayurved Laboratories Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Shalby Ltd changed from ₹ 14.74 crore to ₹ 10.5 crore over 9 quarters. This represents a CAGR of -13.99% The net profit of Vaidya Sane Ayurved Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Shalby Ltd changed from 25.19 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Vaidya Sane Ayurved Laboratories Ltd changed from 5.06 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 years .

About Shalby Ltd

Shalby Limited was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004.
Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006.
Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services.
With 15 hospitals and over 2,300 beds across 12 cities, Shalby is now the largest corporate hospital group in Western and Central India.
The Hospitals are tertiary care hospitals, few of which offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

About Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Ayurved Laboratories Limited was originally incorporated as a Private Limited Company pursuant to a Certificate of Incorporation issued by the Registrar of Companies, Pune dated April 6, 1999 with the name Vaidya Sane Ayurved Laboratories Private Limited'.
Subsequently, Company was converted into to a Public Limited Company and the name of Company was changed to Vaidya Sane Ayurved Laboratories Limited'.
A fresh Certificate of Incorporation upon conversion was issued on November 25, 2021 by the Registrar of Companies, Pune. The Company is a unique medical service institution to treat chronic ailments like cardiac disease, diabetes, hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda.
Its approach to treatment using non-invasive, multidisciplinary and innovative therapies has helped the Company for treating the chronic ailments.

FAQs for the comparison of Shalby Ltd and Vaidya Sane Ayurved Laboratories Ltd

Which company has a larger market capitalization, Shalby Ltd or Vaidya Sane Ayurved Laboratories Ltd?

Market cap of Shalby Ltd is 1,227 Cr while Market cap of Vaidya Sane Ayurved Laboratories Ltd is 153 Cr

What are the key factors driving the stock performance of Shalby Ltd and Vaidya Sane Ayurved Laboratories Ltd?

The stock performance of Shalby Ltd and Vaidya Sane Ayurved Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shalby Ltd and Vaidya Sane Ayurved Laboratories Ltd?

As of October 24, 2026, the Shalby Ltd stock price is INR ₹113.65. On the other hand, Vaidya Sane Ayurved Laboratories Ltd stock price is INR ₹146.45.

How do dividend payouts of Shalby Ltd and Vaidya Sane Ayurved Laboratories Ltd compare?

To compare the dividend payouts of Shalby Ltd and Vaidya Sane Ayurved Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.